Pancreatic Surgery Practice Questions

Q: A patient with obstructive jaundice due to pancreatic cancer might have all of the following clinical findings except?

Pain is early in the course of the disease. ### Explanation **1. Why "Pain is early in the course of the disease" is the Correct Answer:** Pancreatic cancer, particularly in the head of the pancreas, is notorious for being a **"silent killer."** The classic clinical presentation is **painless, progressive obstructive jaundice.** Pain typically develops only in the advanced stages when the tumor invades the celiac plexus or causes significant ductal obstruction. Therefore, early-stage disease is usually asymptomatic or presents only with jaundice and weight loss. **2. Analysis of Incorrect Options:** * **A. A palpable gallbladder:** This refers to **Courvoisier’s Law**, which states that in a patient with obstructive jaundice, if the gallbladder is palpable, the obstruction is unlikely to be due to a stone (as stones cause a fibrotic, non-distensible gallbladder). Instead, it suggests a malignant obstruction (e.g., pancreatic head cancer). * **C. Pulmonary metastasis:** Pancreatic cancer is highly aggressive. While it primarily spreads to the liver and peritoneum, the lungs are the most common site of extra-abdominal visceral metastasis. * **D. Thrombocytopenia:** While not a primary symptom, it can occur in advanced pancreatic cancer due to **disseminated intravascular coagulation (DIC)**, hypersplenism from portal/splenic vein thrombosis, or bone marrow infiltration. **3. High-Yield Clinical Pearls for NEET-PG:** * **Courvoisier’s Sign:** Palpable, non-tender gallbladder + Jaundice = Malignancy (Pancreatic head cancer/Periampullary CA). * **Trousseau’s Sign of Malignancy:** Migratory thrombophlebitis (recurrent blood clots in superficial veins) is a classic paraneoplastic syndrome associated with pancreatic cancer. * **Tumor Marker:** **CA 19-9** is the most specific marker for monitoring response to treatment (not for screening). * **Investigation of Choice:** **CECT (Triple-phase CT)** is the gold standard for diagnosis and staging.

Q: All of the following are true about insulinoma EXCEPT:

It is usually asymptomatic and requires no treatment.. **Explanation:** Insulinoma is the most common functional neuroendocrine tumor (NET) of the pancreas. The correct answer is **Option A** because insulinomas are **never asymptomatic**; they characteristically present with **Whipple’s Triad**: symptoms of hypoglycemia (confusion, sweating, palpitations), documented low blood glucose (<50 mg/dL), and immediate relief of symptoms upon glucose administration. Treatment is mandatory, usually via surgical resection (enucleation), as the hypoglycemia can be life-threatening. **Analysis of other options:** * **Option B:** While 90% of insulinomas are solitary and benign, they are typically **small** (<2 cm). In the context of MEN-1 syndrome, they are frequently **multiple**, making this a characteristic feature to consider during surgical mapping. * **Option C:** Medical management is used for preoperative stabilization or in inoperable cases. **Diazoxide** inhibits insulin release from beta cells, and **Octreotide** (a somatostatin analogue) suppresses insulin secretion by binding to SSTR receptors. * **Option D:** The **pancreas** is the primary site; insulinomas are distributed equally across the head, body, and tail of the pancreas. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 90s:** 90% are solitary, 90% are benign, 90% are <2 cm, and 90% are intrapancreatic. * **Diagnosis:** The gold standard is the **72-hour supervised fast** (showing elevated insulin and C-peptide levels despite hypoglycemia). * **Localization:** Intraoperative ultrasound (IOUS) is the most sensitive method for localization during surgery. * **Association:** If multiple, suspect **MEN-1 syndrome**.

Q: What is the most common complication of the Whipple procedure?

Delayed gastric emptying. The Whipple procedure (Pancreaticoduodenectomy) is a complex surgery involving multiple anastomoses. Understanding its complications is high-yield for NEET-PG. **Correct Answer: A. Delayed Gastric Emptying (DGE)** DGE is the **most common** complication following a Whipple procedure, occurring in approximately **15–40%** of patients. It is defined by the inability to tolerate oral intake by the end of the first postoperative week or the need for prolonged nasogastric tube (NGT) decompression. The underlying pathophysiology is multifactorial, involving the loss of neural pathways (vagotomy effect), reduction in motilin levels (due to duodenal resection), and local inflammation/edema at the gastrojejunostomy. **Explanation of Incorrect Options:** * **B. Bleeding:** While life-threatening (especially if secondary to a sentinel bleed from a pseudoaneurysm), it occurs in less than 10% of cases. * **C. Exocrine Insufficiency:** This is a common **long-term/late** sequela rather than an immediate postoperative complication. * **D. Anastomotic Leak:** Specifically, a **Postoperative Pancreatic Fistula (POPF)** is the most feared and "signature" complication of Whipple’s, but its incidence (approx. 10–15%) is lower than that of DGE. **High-Yield Clinical Pearls for NEET-PG:** * **Most common complication:** Delayed Gastric Emptying. * **Most common cause of mortality:** Postoperative Pancreatic Fistula (POPF) leading to sepsis or hemorrhage. * **ISGPS Criteria:** Complications like DGE and POPF are graded (A, B, C) based on clinical impact. * **Management of DGE:** Primarily conservative (NGT suction, prokinetics like Erythromycin, and nutritional support).

Q: Which of the following is best for the localization of Zollinger-Ellison syndrome?

Endoscopic ultrasound (EUS). **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting tumor (gastrinoma), typically located within the **Gastrinoma Triangle** (Passaro’s Triangle). Localization is a two-step process: biochemical diagnosis followed by anatomical localization. **1. Why Endoscopic Ultrasound (EUS) is correct:** EUS is considered the most sensitive imaging modality for localizing small gastrinomas, especially those located in the **pancreas or the duodenal wall**. It can detect lesions as small as 2–5 mm, which are often missed by conventional CT or MRI. While Somatostatin Receptor Scintigraphy (SRS/Octreoscan) or Ga-68 DOTATATE PET-CT are excellent for whole-body screening, EUS remains superior for precise regional localization and guided biopsy. **2. Why other options are incorrect:** * **Secretin Injection Test:** This is a **biochemical provocative test** used to *diagnose* ZES (a rise in serum gastrin >200 pg/mL is diagnostic). It confirms the presence of the disease but does not localize the tumor. * **Basal Gastric Acid Output (BAO):** This is a diagnostic screening tool. A BAO >15 mEq/hr is suggestive of ZES but provides no information regarding the anatomical site of the tumor. * **MRI:** While useful for detecting liver metastases, MRI has lower sensitivity than EUS or SRS for identifying small primary gastrinomas in the duodenum. **Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle Boundaries:** Junction of cystic/common bile duct, junction of 2nd and 3rd parts of the duodenum, and the neck/body of the pancreas. * **Most common site:** Historically the pancreas, but more recent studies show the **duodenum** is the most common site for primary gastrinomas. * **MEN-1 Association:** 25% of ZES cases occur as part of Multiple Endocrine Neoplasia Type 1. * **Best Initial Imaging:** Ga-68 DOTATATE PET-CT (now preferred over Octreoscan). * **Most Sensitive for Pancreatic Lesions:** EUS.

Q: A 45-year-old female presents with recurrent epigastric abdominal pain and jaundice. Ultrasound shows clusters of cysts with lobulated margins in the head of the pancreas. MRI reveals a multicystic mass with a "bunch of grapes" appearance and a grossly dilated pancreatic duct. What is the most probable diagnosis?

Intraductal papillary mucinous neoplasm (IPMN). ### Explanation The correct diagnosis is **Intraductal Papillary Mucinous Neoplasm (IPMN)**. **1. Why IPMN is correct:** The key diagnostic features in this clinical vignette are the **"bunch of grapes"** appearance and the **grossly dilated pancreatic duct**. IPMNs are mucin-producing epithelial neoplasms that arise within the main pancreatic duct or its side branches. * **Main-duct IPMN:** Characterized by segmental or diffuse dilation of the main pancreatic duct (>5 mm). * **Side-branch IPMN:** Presents as a multicystic lesion (the "bunch of grapes") communicating with the duct. The presence of jaundice suggests involvement of the pancreatic head, potentially causing biliary obstruction. **2. Why other options are incorrect:** * **Serous Cystadenoma:** Typically presents with a "honeycomb" appearance and a **central stellate scar** with calcification. It does not communicate with or cause gross dilation of the pancreatic duct. * **Mucinous Cystadenoma:** Usually occurs in the **body or tail** of the pancreas in middle-aged women. It consists of large, unilocular or macrocystic lesions (usually <6 cysts) and lacks ductal communication. * **Solid Pseudopapillary Epithelial Neoplasm (SPEN):** Typically seen in **young females** ("Frantz tumor"). It appears as a large, well-circumscribed mass with both solid and cystic (hemorrhagic/necrotic) components, rather than a cluster of small cysts. **3. High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic Sign:** Visualization of mucin extruding from a "fish-mouth" ampulla during ERCP is diagnostic for IPMN. * **Malignant Potential:** Main-duct IPMNs have a much higher risk of malignancy (up to 60-70%) compared to side-branch IPMNs. * **Rule of Gender:** Remember "Mother" (Mucinous - middle-aged female), "Grandmother" (Serous - elderly female), and "Daughter" (SPEN - young female). IPMN affects males and females more equally.

Q: What is the primary diagnostic investigation for carcinoma of the pancreas?

MDCT (Multidetector Computed Tomography). **Explanation:** **MDCT (Multidetector Computed Tomography)** is the gold standard and primary diagnostic investigation for pancreatic carcinoma. The "Pancreatic Protocol" CT involves thin-slice (0.5–1 mm) imaging during the late arterial and portal venous phases. It is preferred because it provides high-resolution details of the primary tumor, its relationship to major peripancreatic vessels (SMA, Celiac axis, Portal vein), and the presence of distant metastases. This allows for simultaneous diagnosis and **staging (resectability assessment)**, which is crucial for surgical planning. **Why other options are incorrect:** * **PET Scan:** While useful for detecting occult distant metastases, it lacks the anatomical detail required for local staging and resectability assessment. It is not a first-line diagnostic tool. * **ERCP:** Historically used for diagnosis, it is now primarily a **therapeutic** intervention. It is reserved for biliary drainage (stenting) in patients with obstructive jaundice or for obtaining brush cytology if the diagnosis is unclear. It is invasive and carries a risk of pancreatitis. * **MRCP:** Excellent for visualizing the biliary tree and pancreatic duct (showing the "Double Duct Sign"), but it is generally inferior to MDCT for assessing vascular invasion and overall resectability. **High-Yield Clinical Pearls for NEET-PG:** * **Double Duct Sign:** Simultaneous dilatation of the Common Bile Duct and Pancreatic Duct; highly suggestive of a head of pancreas or periampullary tumor. * **Tumor Marker:** **CA 19-9** is the most specific marker for monitoring prognosis and recurrence, but not for primary screening (as it can be elevated in benign jaundice). * **Courvoisier’s Law:** In a patient with obstructive jaundice, if the gallbladder is palpable, the obstruction is unlikely to be a stone (suggests malignancy).

Q: What is a pseudopancreatic cyst?

A cyst that develops following inflammation. ### Explanation A **pseudopancreatic cyst** (or pancreatic pseudocyst) is a localized collection of pancreatic fluid, rich in digestive enzymes, surrounded by a wall of fibrous or granulation tissue. **Why Option B is correct:** The most common etiology for a pseudocyst is **acute pancreatitis** (inflammation). Following an episode of inflammation, pancreatic ductal disruption occurs, leading to the leakage of secretions. Unlike true cysts, pseudocysts lack an epithelial lining; instead, the body walls off the fluid using adjacent organs (stomach, duodenum, or pancreas) and inflammatory fibrosis. **Analysis of Incorrect Options:** * **Option A:** While trauma can cause a pseudocyst, it is not the defining characteristic. Inflammation (from any cause, including alcohol or gallstones) is the primary pathophysiological driver. * **Option C:** Cysts present from birth are **congenital cysts** (e.g., polycystic disease or dermoid cysts), which possess a true epithelial lining. * **Option D:** Cysts that are tumors are classified as **cystic neoplasms** (e.g., Serous Cystadenoma, Mucinous Cystic Neoplasm, or IPMN). These are neoplastic growths, not inflammatory collections. **NEET-PG High-Yield Pearls:** * **Timeframe:** A pseudocyst typically takes **4–6 weeks** to form after an episode of acute pancreatitis. * **Location:** Most commonly found in the **lesser sac**. * **Diagnosis:** **CECT** is the gold standard for diagnosis and monitoring. * **Management:** Most resolve spontaneously. Intervention (e.g., endoscopic cystogastrostomy) is indicated only if the cyst is symptomatic, infected, or rapidly enlarging. * **Key Distinction:** If the collection occurs within the first 4 weeks and lacks a defined wall, it is termed an **Acute Peripancreatic Fluid Collection (APFC)**.

Q: What is the best prognosis for carcinoma of the pancreas?

Periampullary. ### Explanation The prognosis of pancreatic and peripancreatic cancers is primarily determined by the **timing of clinical presentation** and the **resectability** at the time of diagnosis. **Why Periampullary is the correct answer:** Periampullary carcinomas (which include tumors of the ampulla of Vater, distal common bile duct, and duodenum) have the **best prognosis** because they present early. Due to their anatomical location, even small tumors cause early biliary obstruction, leading to **painless progressive jaundice**. This early symptom prompts medical evaluation while the tumor is still small and localized, resulting in a higher rate of surgical resectability (Whipple’s procedure) and better 5-year survival rates (30–50%) compared to true pancreatic ductal adenocarcinoma. **Why other options are incorrect:** * **Head of Pancreas:** While these also present with jaundice, they tend to be more aggressive biologically than periampullary tumors. By the time they cause symptoms, they often involve local vessels or lymph nodes. * **Body and Tail:** These are known as the "silent killers" of the pancreas. Because they do not obstruct the bile duct early, they remain asymptomatic until they reach a large size or metastasize. They typically present with weight loss and back pain, and the majority are unresectable at the time of diagnosis, leading to the worst prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most common periampullary tumor:** Carcinoma of the head of the pancreas (but it has the worst prognosis among the group). * **Best prognosis among periampullary tumors:** Ampullary carcinoma. * **Courvoisier’s Law:** In a patient with painless jaundice and a palpable gallbladder, the cause is unlikely to be gallstones (usually malignancy). * **Double Duct Sign:** Dilatation of both the common bile duct and the pancreatic duct on imaging, highly suggestive of a tumor in the head of the pancreas or ampulla.

Question 1

A patient with obstructive jaundice due to pancreatic cancer might have all of the following clinical findings except?

Accepted Answer

Pain is early in the course of the disease

Answer

A palpable gallbladder

Answer

Pulmonary metastasis

Answer

Thrombocytopenia

Question 2

All of the following are true about insulinoma EXCEPT:

Accepted Answer

It is usually asymptomatic and requires no treatment.

Answer

It is usually small and multiple.

Answer

Diazoxide and octreotide reduce insulin synthesis.

Answer

The most common site is the pancreas.

Question 3

What is the most common complication of the Whipple procedure?

Accepted Answer

Delayed gastric emptying

Answer

Bleeding

Answer

Exocrine insufficiency

Answer

Anastomotic leak

Question 4

Which of the following is best for the localization of Zollinger-Ellison syndrome?

Accepted Answer

Endoscopic ultrasound (EUS)

Answer

Secretin injection test

Answer

Magnetic resonance imaging (MRI)

Answer

Basal gastric acid output

Question 5

A 45-year-old female presents with recurrent epigastric abdominal pain and jaundice. Ultrasound shows clusters of cysts with lobulated margins in the head of the pancreas. MRI reveals a multicystic mass with a "bunch of grapes" appearance and a grossly dilated pancreatic duct. What is the most probable diagnosis?

Accepted Answer

Intraductal papillary mucinous neoplasm (IPMN)

Answer

Serous cystadenoma

Answer

Mucinous cystadenoma

Answer

Solid pseudopapillary epithelial neoplasm

Question 6

What is the primary diagnostic investigation for carcinoma of the pancreas?

Accepted Answer

MDCT (Multidetector Computed Tomography)

Answer

PET scan (Positron Emission Tomography scan)

Answer

ERCP (Endoscopic Retrograde Cholangiopancreatography)

Answer

MRCP (Magnetic Resonance Cholangiopancreatography)

Question 7

Which of the following are the imaging criteria for unresectable carcinoma of the pancreas?

Accepted Answer

All the above

Answer

Metastatic spread to vertebrae

Answer

Invasion in the duodenal wall

Answer

Irregular increase in density of omental fat

Question 8

What is a pseudopancreatic cyst?

Accepted Answer

A cyst that develops following inflammation

Answer

A cyst that occurs after trauma

Answer

A cyst present from birth

Answer

A cyst that is a tumor

Question 9

What is the best prognosis for carcinoma of the pancreas?

Accepted Answer

Periampullary

Answer

Head

Answer

Tail

Answer

Body

Question 10

Which of the following is not a contraindication for resection of the head of the pancreas?

Accepted Answer

Ascites

Answer

Liver metastasis

Answer

Peritoneal seedings

Answer

Involvement of a major artery

Pancreatic Surgery — MCQs

Pancreatic Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?